My Specialization in Microbiology with interdisciplinary research expertise spanning nanobiotechnology, antimicrobial resistance, ferrofluid synthesis, and computational bioinformatics approaches. His research primarily focuses on the development and characterization of functional nanomaterials, including oleic acid-coated Fe₃O₄ nanoparticles, and their biomedical and environmental applications. He has significant experience in hydrothermal and solvothermal synthesis techniques, nanoparticle surface functionalization, and advanced physicochemical characterization methods.
I am also actively engaged in omics-driven and in silico methodologies, including molecular docking and bioinformatics analysis, particularly targeting emerging and drug-resistant pathogens. His research interests include probiotic therapeutics, metabolic determinants of antibiotic tolerance in ESKAPE pathogens, and nanomaterial-based drug delivery systems. He has contributed to several research articles, review papers, and conference presentations at national and international platforms. His long-term research vision integrates nanotechnology, microbiology, and computational biology to develop innovative solutions for infectious diseases and translational biomedical applications.
My Specialization in Microbiology with interdisciplinary research expertise spanning nanobiotechnology, antimicrobial resistance, ferrofluid synthesis, and computational bioinformatics approaches. His research primarily focuses on the development and characterization of functional nanomaterials, including oleic acid-coated Fe₃O₄ nanoparticles, and their biomedical and environmental applications. He has significant experience in hydrothermal and solvothermal synthesis techniques, nanoparticle surface functionalization, and advanced physicochemical characterization methods.
I am also actively engaged in omics-driven and in silico methodologies, including molecular docking and bioinformatics analysis, particularly targeting emerging and drug-resistant pathogens. His research interests include probiotic therapeutics, metabolic determinants of antibiotic tolerance in ESKAPE pathogens, and nanomaterial-based drug delivery systems. He has contributed to several research articles, review papers, and conference presentations at national and international platforms. His long-term research vision integrates nanotechnology, microbiology, and computational biology to develop innovative solutions for infectious diseases and translational biomedical applications.